Subscribe to our newsletter.
The VeriDose® DPYD Panel emerges as an avant-garde solution for accurate detection of dihydropyrimidine dehydrogenase (DPD) enzyme functionality variations. Its brilliance lies in its capability to concurrently detect a set of 9 DPYD variants associated with an increased risk of severe toxicity. Such a multiplexed detection system accelerates the diagnostic process, yielding decisive results efficiently.
A distinguishing feature of this panel is its integrated positive control system. Mimicking a heterozygous genotype, this control serves a dual purpose. It not only guarantees the impeccable functioning of the PCR system but also aids in streamlining the qualitative analysis interpretation.
Efficiency and Integration
Precision and Application
In summation, as pharmacogenetic analysis advances, tools like the VeriDose® DPYD Panel are at the forefront. This innovative product epitomizes not only scientific progression but also represents the future of precise and streamlined laboratory diagnostics.
For laboratory professionals navigating the choices of pharmacogenetic investigative tools, understanding the virtues of this panel is crucial. It presents a harmonious combination of efficiency, compliance, precision, and versatility—attributes highly valued in contemporary laboratories.
Amid the vast array of scientific equipment and tools, the VeriDose® DPYD Panel stands distinguished. It not only exemplifies the significant strides made in laboratory science but also the promising trajectory it is set upon.